rdf:type |
|
lifeskim:mentions |
|
pubmed:issue |
6
|
pubmed:dateCreated |
2004-2-25
|
pubmed:abstractText |
Introduction of genes encoding immuno-stimulatory cytokine(s) into cancer cells is well known to enhance anti-tumour immunity.
|
pubmed:language |
eng
|
pubmed:journal |
|
pubmed:citationSubset |
IM
|
pubmed:chemical |
|
pubmed:status |
MEDLINE
|
pubmed:month |
Dec
|
pubmed:issn |
0300-0664
|
pubmed:author |
|
pubmed:issnType |
Print
|
pubmed:volume |
59
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
734-42
|
pubmed:dateRevised |
2006-4-21
|
pubmed:meshHeading |
pubmed-meshheading:14974915-Adenoviridae,
pubmed-meshheading:14974915-Animals,
pubmed-meshheading:14974915-Cell Line, Tumor,
pubmed-meshheading:14974915-Gene Expression,
pubmed-meshheading:14974915-Gene Therapy,
pubmed-meshheading:14974915-Genetic Engineering,
pubmed-meshheading:14974915-Genetic Vectors,
pubmed-meshheading:14974915-Granulocyte-Macrophage Colony-Stimulating Factor,
pubmed-meshheading:14974915-Immunotherapy, Active,
pubmed-meshheading:14974915-Injections, Intralesional,
pubmed-meshheading:14974915-Interleukin-12,
pubmed-meshheading:14974915-Male,
pubmed-meshheading:14974915-Models, Animal,
pubmed-meshheading:14974915-Neoplasm Transplantation,
pubmed-meshheading:14974915-Rats,
pubmed-meshheading:14974915-Rats, Inbred F344,
pubmed-meshheading:14974915-Retroviridae,
pubmed-meshheading:14974915-Thyroid Neoplasms,
pubmed-meshheading:14974915-Transduction, Genetic
|
pubmed:year |
2003
|
pubmed:articleTitle |
Thyroid cancer immuno-therapy with retroviral and adenoviral vectors expressing granulocyte macrophage colony stimulating factor and interleukin-12 in a rat model.
|
pubmed:affiliation |
Department of Pharmacology 1, Nagasaki University Graduate School of Biomedical Sciences, Japan.
|
pubmed:publicationType |
Journal Article
|